Skip to content
Sunday, May 28, 2023
Latest:
  • Is there hidden meaning in “madness”?
  • Changes in gene p16 create a permissive microenvironment for colon cancer growth
  • A new education and health sciences building, a new era for Baylor and the TMC
  • The link between cancer, obesity and metabolic health
  • Breast cancer tumors remotely disrupt immune response that could stop their own growth

Baylor College of Medicine Blog Network

Baylor College of Medicine Blog Network

  • Home
  • Momentum
    • About Momentum
    • Resources
    • Contributors
      • Dana Benson
      • Molly Chiu
      • Julie Garcia
      • Graciela Gutierrez
      • Anna Kiappes
      • Dipali Pathak
      • Andy Phifer
      • Homa Shalchi
      • Melissa Tucker
    • Contact Us
  • From The Labs
    • About From the Labs
    • Follow From The Labs on Twitter
  • Policywise
    • About PolicyWise
    • Follow @BCMEthics on Twitter
  • The Stitch
    • About The Stitch
  • Progress Notes
    • About Progress Notes
    • Progress Notes Editors
    • Connect With Us
  • bcm.edu

pralsetinib

From The Labs 

Discovering targetable vulnerabilities in endocrine therapy-resistant breast cancer

May 16, 2023May 16, 2023endocrine therapy-resistant breast cancer, ER+ breast cancer, estrogen receptor 1, fusion genes, pralsetinib, Research, RET kinase

The findings support evaluating targeting kinase enzymes in a clinical trial to treat this type of breast cancer.

Read more

From the Labs Image of the Month

From The Labs Image of the Month From the Labs: The Liver’s biliary tree

Healthy Habits: A DOC-umentary Series

https://www.youtube.com/watch?v=SlNiMWHUhbc

Archives

Search

©1998 - 2020 Baylor College of Medicine®
One Baylor Plaza, Houston, Texas 77030
(713) 798-4951